Effects of cholestyramine and lovastatin upon plasma lipids and egg yolk cholesterol levels of laying hens
The purpose of this study was to evaluate the effect of cholestyramine and lovastatin, lipid-lowering agents, upon egg quality, reproductive performance, plasma lipids and egg yolk cholesterol levels of Shaver laying hens. Twenty-six-weeks-old hens were fed basal diet without animal products containing 0.2% cholestyramine (COL1), 0.3% cholestyramine (COL2) or 0.005% lovastatin (LOV) for 6 weeks. It was observed that the supplementation of the drugs did not impair albumen and shell quality. Hen performance was not adversely affected, with the exception of the significant reduction (p < 0.05) in egg weights. No significant changes were observed on plasma lipids, and egg yolk cholesterol remained unchanged with the addition of the drugs.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Faculdade de Medicina Veterinária e Zootecnia / Universidade de São Paulo
2000
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-95962000000100015 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The purpose of this study was to evaluate the effect of cholestyramine and lovastatin, lipid-lowering agents, upon egg quality, reproductive performance, plasma lipids and egg yolk cholesterol levels of Shaver laying hens. Twenty-six-weeks-old hens were fed basal diet without animal products containing 0.2% cholestyramine (COL1), 0.3% cholestyramine (COL2) or 0.005% lovastatin (LOV) for 6 weeks. It was observed that the supplementation of the drugs did not impair albumen and shell quality. Hen performance was not adversely affected, with the exception of the significant reduction (p < 0.05) in egg weights. No significant changes were observed on plasma lipids, and egg yolk cholesterol remained unchanged with the addition of the drugs. |
|---|